Non-steroidal anti-inflammatory drug induces luteinized unruptured follicle syndrome in young female juvenile idiopathic arthritis patients

To assess prospectively luteinized unruptured follicle (LUF) syndrome in juvenile idiopathic arthritis (JIA) patients with and without non-steroidal anti-inflammatory drugs (NSAIDs) and healthy controls. Twenty-three adolescent and young adult female JIA patients (ILAR criteria) and 11 female healthy subjects were studied by pelvic ultrasound monitoring for follicular development and ovulation in one menstrual cycle. LUF syndrome was prospectively investigated by pelvic ultrasound with a dominant ovarian follicle without signs of follicular rupture, with elevation of serum progesterone in the luteal phase of the menstrual cycle and luteinizing hormone (LH) detected in the urine. Comparison between JIA patients with (n = 8) vs. without NSAIDs (n = 15) and healthy controls (n = 11) revealed that LUF syndrome was significantly higher in the former group (2 (25%) vs. 0% vs. 0%, p = 0.049). These two patients with LUF syndrome had normal menstrual cycles without reduced ovarian reserve, and they were under naproxen 500 mg bid during the menstrual cycle. Disease duration was comparable in JIA with and without NSAIDs [19.8 (4.4–25) vs. 13 (3.1–33) years, p = 0.232]. Further comparison between JIA patients with and without NSAIDs and healthy controls showed similar mean anti-Müllerian hormone levels (p = 0.909), estradiol (p = 0.436), FSH (p = 0.662), LH (p = 0.686), and mean antral follicle count (p = 0.240) and ovarian volume (p = 0.363). No differences were evidenced in three groups regarding Caucasian race, body mass index, duration, and length of menstrual cycles (p > 0.05). This is the first study to identify that JIA patients have a high frequency of LUF without impaired ovarian reserve. Future prospective studies are necessary to determine if chronic/continuous use of NSAIDs in JIA will have an impact in these patients’ fertility. Access this article We’re sorry, something doesn't seem to be working properly. Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Silva CA, Yamakami LY, Aikawa NE, Araujo DB, Carvalho JF, Bonfá E (2014) Autoimmune primary ovarian insufficiency. Autoimmun Ver 13(4–5):427–430 Aikawa NE, Sallum AM, Leal MM, Bonfá E, Pereira RM, Silva CA (2010) Menstrual and hormonal alterations in juvenile dermatomyositis. Clin Exp Rheumatol Jul-Aug 28(4):571–575 Mont'Alverne AR, Yamakami LY, Gonçalves CR, Baracat EC, Bonfá E, Silva CA (2015) Diminished ovarian reserve in Behçet’s disease patients. Clin Rheumatol 34(1):179–183 Smith G, Roberts R, Hall C, Nuki G (1996) Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Br J Rheumatol 35(5):458–462 Akil M, Amos RS, Stewart P (1996) Infertility may sometimes be associated with NSAID consumption. Br J Rheumatol 35(1):76–78 Micu MC, Micu R, Ostensen M (2011) Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. Arthritis Care Res 63(9):1334–1338 Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390–392 Medeiros PB, Febronio MV, Bonfa E, Borba EF, Takiuti AD, Silva CA (2009) Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 18:38–43 Silva CA, Leal MM, Leone C, Simone VP, Takiuti AD, Saito MI et al (2002) Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. Lupus 11(7):419–425 Vermesh M, Kletzky OA, Davajan V, Israel R (1987) Monitoring techniques to predict and detect ovulation. Fertil Steril 47:259–264 Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R (2009) Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod 24:867–875 Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ (2005) Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 83:291–301 Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ (2007) Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 87:764–775 Jesam C, Salvatierra AM, Schwartz JL, Fuentes A, Croxatto HB (2014) Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial. Contraception 90(2):168–173 Silva CA, Bonfa E, Østensen M (2010) Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res 62:1682–1690 Silva CA, Brunner HI (2007) Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 16:593–599 Palmer BF, Clegg DJ (2017) Gonadal dysfunction in chronic kidney disease. Rev Endocr Metab Disord 18(1):117–130 de Araujo DB, Yamakami LY, Aikawa NE, Bonfá E, Viana VS, Pasoto SG, Pereira RMR, Serafin PC, Borba EF, Silva CA (2014) Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol 43(6):503–511 Bata MS, Al-Ramahi M, Salhab AS, Gharaibeh MN, Schwartz J (2006) Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study. J Clin Pharmacol 46(8):925–932 Mendonça LL, Khamashta MA, Nelson-Piercy C, Hunt BJ, Hughes GR (2000) Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology (Oxford) 39(8):880–882 Funding This study was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 305068/2014-8 to EB and 303422/2015-7 to CAS), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2014/14806-0 and 2015/03756-4 to EB and CAS), Federico Foundation (to CAS) and by Núcleo de Apoio à Pesquisa “Saúde da Criança e do Adolescente” da USP (NAP-CriAd) to CAS. Author information Authors and Affiliations Corresponding author Ethics declarations The Local Ethics Committee of our tertiary service approved the study, and an informed consent was obtained from all participants and their legal guardian. Disclosure None. Rights and permissions About this article Cite this article Tomioka, R.B., Ferreira, G.R.V., Aikawa, N.E. et al. Non-steroidal anti-inflammatory drug induces luteinized unruptured follicle syndrome in young female juvenile idiopathic arthritis patients. Clin Rheumatol 37, 2869–2873 (2018). https://doi.org/10.1007/s10067-018-4208-x Received: Revised: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s10067-018-4208-x